Analysis of Single Respiratory Viral Infections Versus Co-infections: Prevalence and ICU Needs in Hospitalized Adults
Launched by KOCAELI UNIVERSITY · Jan 12, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study aims to determine the prevalence of viral respiratory agents in hospitalized patients post-COVID-19 and to examine the clinical course of respiratory viral co-infections, which are expected to be more severe.
This study will be conducted retrospectively at Kocaeli University Hospital between May 2023, considered the end date of the pandemic, and January 2024. Patients over 18 years of age will be included, and data will be accessed through the hospital automation system. Patients with SARS-CoV-2 PCR-positive symptoms and those expected to use molnupiravir due to the need for tre...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 18 years of age
- • Patients admitted to our clinic or consulted to infectious diseases from other inpatient services.
- • Patients diagnosed with upper or lower respiratory tract infections due to viral agents
- Exclusion Criteria:
- • Patients infected with bacterial agents will not be included in the study.
- • Patients admitted from the outpatient clinic were not included in the study plan.
About Kocaeli University
Kocaeli University, a prominent institution in Turkey, is dedicated to advancing medical research and education through its comprehensive clinical trial initiatives. With a focus on innovative healthcare solutions, the university collaborates with leading researchers and healthcare professionals to conduct rigorous scientific studies aimed at improving patient outcomes. By fostering an environment of academic excellence and interdisciplinary collaboration, Kocaeli University aims to contribute significantly to the global medical community while ensuring adherence to ethical standards and regulatory guidelines in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kocaeli, , Turkey
Patients applied
Trial Officials
Özlem Güler, Assist. Prof
Principal Investigator
Kocaeli University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported